Since Prior authorisation keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience will review it.
Follow-up: Prior authorisation: what the criteria usually require posts 91–101
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.
Quietly grateful for the plain phrasing. Not every thread gets that.
I had written a reply contradicting post #90 and deleted it. Here is what survived.
Formulary changes happen on a published schedule, so a denial now may be answering criteria that change shortly.
The interesting part of this is the exception, and I do not understand the exception.
I would call the community position on Prior authorisation likely rather than established, and I would be comfortable defending that hedge.
One more thing on Prior authorisation that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent contradiction disappears.
Everything in post #98 holds. The case it does not cover is the one I have.
Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently.
A note on how Prior authorisation gets discussed rather than on Prior authorisation itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.
This topic was referenced in
- [2026 update] Documentation that materially improves an appeal's chancesAccess › Insurance & coverage · 2 replies
- [2026 update] Step therapy requirements and how to satisfy themAccess › Insurance & coverage · 122 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Prior authorisation: what the criteria usually require
On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…
|
+9 | 13 | 3.2k | 17mo |
|
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…
|
+125 | 138 | 9.4k | 10mo |
|
Documentation that materially improves an appeal's chances
Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about documentation rather than a disguised assertion. I…
|
+93 | 98 | 3.6k | 8mo |
|
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. The question about peer-to-peer review that I actually want answered is the second…
|
2 | 1.2k | 1d | |
|
Coverage for the indication versus for the drug
Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want answered is the second one below. The…
|
+70 | 79 | 18k | 14mo |
Related topics — sharing the tags insurance, appeals, formulary
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…
|
+125 | 138 | 9.4k | 10mo |
|
Hoarding and why it makes a shortage worse
Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
2 | 12k | 22mo | |
|
Coverage for the indication versus for the drug — a second dataset
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and…
|
+46 | 50 | 41k | 16mo |
|
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
|
+70 | 74 | 7k | 8mo |
|
Follow-up: External review after an internal denial
Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. Proposing that External review deserves a maintained page rather than a…
|
+6 | 10 | 12k | 15h |